About CoreBiome
CoreBiome is a Healthcare company based in Minneapolis (United States) founded in 2016, and was acquired by OraSure in January 2019. Microbiome diversity is analyzed using big data methods. CoreBiome has raised $1.35 million across 2 funding rounds from investors including OraSure Technologies, Gopher Angels and Microbiologics. The company was acqui-hired. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its competitors include Evelo Biosciences, Trace Genomics and Seven Bridges Genomics; 3 of its 3 listed competitors have raised funding.
Company details
CoreBiome was founded in 2016 and is based in Minneapolis, United States. Proprietary methods are developed by the company for measuring and interpreting microbial diversity through DNA sequencing and AIML-based analytics. End-to-end solutions are offered, encompassing sample processing, sequencing, and comprehensive data analysis in the microbiome sector. Operations focus on precise microbial assessment for research and applications.
- Headquarters Minneapolis, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website corebiome.com
- Acquired by OraSure (Jan 2019)
- Total Equity Funding$1.35M (USD)
in 2 rounds
- Latest Funding Round$550K (USD), Seed
Aug 2018
- InvestorsOraSure Technologies
& 2 more
- Acquired byOraSure
(Jan 2019)
Funding Insights of CoreBiome
CoreBiome has successfully raised a total of $1.35M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $550 thousand completed in August 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.35M
- Total Rounds 2
- Last Round Seed — $550,000
- First Round $800,000
(Jul 2017)
- Investors Count 2
All 2 funding rounds of CoreBiome with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2018 | $550,000 | Seed | – | – | – |
| Jul 2017 | $800,000 | Seed | – | Gopher Angels, Microbiologics | – |
3 investors in total: 2 institutional and 1 angel.
Investors in CoreBiome
CoreBiome has secured backing from 3 investors, including venture fund and angel investors. Prominent investors backing the company include OraSure Technologies, Gopher Angels and Microbiologics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Angel investment network is focused on Midwest startup growth. | 2012 | gopherangels.com | United States | |
M Microbiologics | unknown_29c95bb0f96f4e0fb | |||
Point-of-care diagnostic devices for oral fluid specimens are provided. | 1987 | orasure.com | Bethlehem, United States |
Investor details for CoreBiome
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CoreBiome
1 people are tracked at CoreBiome (1 in leadership).
| Name | Role | Group |
|---|---|---|
Dan Knights | CEO | Leadership |
Complete people profiles for CoreBiome
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CoreBiome
4 dated milestones of CoreBiome across 3 years, from founding to its latest funding, stage changes and deals.
- Founded CoreBiome is founded.
- Funding First funding round of $800K.
- Funding Latest funding round, Seed, of $550K.
- Exit Acquired by OraSure.
Competitors of CoreBiome
CoreBiome has 3 listed competitors in our database, 3 of them funded. They include Evelo Biosciences, Trace Genomics and Seven Bridges Genomics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| evelobio.com | 2015 | Cambridge, United States | $166.5M | 117 | Therapeutics for inflammatory diseases, COVID-19, and cancer are developed. | |
| tracegenomics.com | 2015 | San Francisco, United States | $53.62M | 51 | Developer of technologies to diagnose soil health and soil-borne disease prediction | |
| sevenbridges.com | 2009 | Cambridge, United States | $113M | 112 | Cloud-based platform to analyze, store, and act on genomic data. |
Detailed competitors of CoreBiome
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as CoreBiome (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Corebiome
Complete news archive for CoreBiome
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CoreBiome
CoreBiome was founded in 2016 and raised its 1st funding round 1 year after it was founded.
CoreBiome is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
CoreBiome is a funded company, having raised a total of $1.35M across 2 funding rounds to date. The company's 1st funding round was a Seed of $800K, raised on Jul 2017.
CoreBiome was founded in 2016 and is based in Minneapolis, United States. Proprietary methods are developed by the company for measuring and interpreting microbial diversity through DNA sequencing and AIML-based analytics. End-to-end solutions are offered, encompassing sample processing, sequencing, and comprehensive data analysis in the microbiome sector. Operations focus on precise microbial assessment for research and applications.
CoreBiome's top competitors include Trace Genomics, Seven Bridges Genomics and Evelo Biosciences.
CoreBiome has 3 investors. Key investors include OraSure Technologies, Gopher Angels, and Microbiologics.
Yes. CoreBiome was acquired by OraSure in January 2019.